CTRI/2020/05/025430
Not yet recruiting
Phase 1
A Cross Sectional Study To Observe The Health Status Of Personnels Engaged In Care Of Covid-19 Infected/Suspected Persons And Receiving Ayurveda Immuno-Modulator Drugs In Jodhpur City - CSOSC
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dabur India Ltd
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Person deployed in quarentine ward
- •Person on hard duty
- •family members of health care personnel
- •willingness to participate in study
- •Taking Ayurveda immunomodulator drugs ( Tab. Maha Sudarshan vati \+ Tab Samshamani Vati \+ Tab. Haridra
Exclusion Criteria
- •Person below 18 yrs \& above 65 yrs
- •Preganant women
- •Any medical condition for which the person is recieing any immunosupressive medicine
- •Known case of malignancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To observe the impact of Ayurveda Kwath in Healthy and Suspected persons for COVID-19CTRI/2020/06/025526Dr SR Rajasthan Ayurved University
Completed
Not Applicable
Cross-sectional observational study on health literacy and choice of complementary and alternative medicine in cancer patientsCancerJPRN-UMIN000049409Kyoto University Hospital2,068
Not yet recruiting
Not Applicable
Health-related quality of life and problems faced among Thalassemia patientsHealth Condition 1: D561- Beta thalassemiaCTRI/2024/07/070456Helan Anna Joseph
Recruiting
Not Applicable
Cross-sectional study to assess the health-related quality of life in patients with complex univentricular heart defects after Fontan surgeryQ20.4Q22.4Q23.4Double inlet ventricleCongenital tricuspid stenosisHypoplastic left heart syndromeDRKS00023120Deutsches Herzzentrum Berlin200
Active, not recruiting
Not Applicable
A Cohort Study for Observing Long-Term Health Status of the Faculty of Semyuong UniversityKCT0006409Korea Institute of Oriental Medicine200